Absci (ABSI) Preferred Dividend Payments (2020 - 2021)
Absci (ABSI) reported Preferred Dividend Payments of $242000.0 for Q3 2021, down 97.37% on a YoY basis from $9.2 million in Q3 2020, and down 76.89% sequentially from $1.0 million in Q2 2021.
Absci (ABSI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Absci (ABSI) has 2 years of Preferred Dividend Payments data on file, last reported at $242000.0 in Q3 2021.
- For the quarter ending Q3 2021, Preferred Dividend Payments fell 97.37% year-over-year to $242000.0; the trailing twelve-month figure through Jun 2022 stood at $242000.0 (down 97.99% YoY), and the FY2021 full-year result was $2.3 million, up 192.82% from the prior year.
- Preferred Dividend Payments fell to $242000.0 in Q3 2021, from $1.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $9.2 million in Q3 2020 to a low of $242000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Absci | 1.16 Bn | 1.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 242,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 995,000.00 |
| Dec 31, 2020 | 780,000.00 |
| Sep 30, 2020 | 9.22 Mn |